Business Wire
BusinessJensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gainsThe Apex TimesBusinessAMD says it is expanding its AI infrastructure footprint in Saudi ArabiaThe Apex TimesBusinessVerizon readies network resources as Tropical Storm Edouard nearsThe Apex TimesBusinessNvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlationsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipelineThe Apex TimesBusinessNvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AIThe Apex TimesBusinessBoeing to resume contract talks with engineers, as strike threat remains on the tableThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging it manipulated online ad auctionsThe Apex TimesBusinessAlphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source librariesThe Apex TimesBusinessKKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billionThe Apex TimesBusinessDeere shares rise after Baird upgrade to OutperformThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessJensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gainsThe Apex TimesBusinessAMD says it is expanding its AI infrastructure footprint in Saudi ArabiaThe Apex TimesBusinessVerizon readies network resources as Tropical Storm Edouard nearsThe Apex TimesBusinessNvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlationsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipelineThe Apex TimesBusinessNvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AIThe Apex TimesBusinessBoeing to resume contract talks with engineers, as strike threat remains on the tableThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging it manipulated online ad auctionsThe Apex TimesBusinessAlphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source librariesThe Apex TimesBusinessKKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billionThe Apex TimesBusinessDeere shares rise after Baird upgrade to OutperformThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessJensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gainsThe Apex TimesBusinessAMD says it is expanding its AI infrastructure footprint in Saudi ArabiaThe Apex TimesBusinessVerizon readies network resources as Tropical Storm Edouard nearsThe Apex TimesBusinessNvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlationsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipelineThe Apex TimesBusinessNvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AIThe Apex TimesBusinessBoeing to resume contract talks with engineers, as strike threat remains on the tableThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging it manipulated online ad auctionsThe Apex TimesBusinessAlphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source librariesThe Apex TimesBusinessKKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billionThe Apex TimesBusinessDeere shares rise after Baird upgrade to OutperformThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessJensen Huang’s “Buy at a Discount” remark returns to focus as Nvidia shares rise and an AI basket gainsThe Apex TimesBusinessAMD says it is expanding its AI infrastructure footprint in Saudi ArabiaThe Apex TimesBusinessVerizon readies network resources as Tropical Storm Edouard nearsThe Apex TimesBusinessNvidia shares show a rare trading pattern, underscoring how investors are rethinking semiconductor correlationsThe Apex TimesBusinessEli Lilly to buy Merida Biosciences in up-to $2.875 billion cash deal, betting on an expanded autoimmune pipelineThe Apex TimesBusinessNvidia backs MediaTek with $3.5 billion convertible-bond deal, indicating a push for local AIThe Apex TimesBusinessBoeing to resume contract talks with engineers, as strike threat remains on the tableThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging it manipulated online ad auctionsThe Apex TimesBusinessAlphabet’s Google says Gemini-powered “Teamwork” agents solved open math, built a CPU simulator, and improved core open-source librariesThe Apex TimesBusinessKKR’s “mini Berkshire” push shows early results as it sells USI assets for about $17 billionThe Apex TimesBusinessDeere shares rise after Baird upgrade to OutperformThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex Times
Back to front
Target recalls Up & Up baby wipes after FDA testing finds potentially harmful bacteria
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 7, 1:28 AM EDT

Target recalls Up & Up baby wipes after FDA testing finds potentially harmful bacteria

The company is pulling specific sizes and lot/date-code ranges of its store-brand wipes, citing customer complaints of discoloration and FDA-identified contamination with Burkholderia cepacia complex and Burkholderia gladioli.

Target said it is voluntarily recalling select Up & Up baby wipes nationwide after customer complaints about discoloration and subsequent FDA testing identified Burkholderia cepacia complex and Burkholderia gladioli in product samples. The recall covers two varieties: Up & Up Fragrance Free Baby Wipes and Up & Up Fresh Cucumber Scented Baby Wipes, sold at Target stores nationwide and. FDA recall announcement.

The FDA notice lists the affected products by size, UPC, and manufacturing/expiration code ranges, rather than recalling the entire line. For example, the fragrance-free option includes 20-count (UPC 085239265956) through 1200-count (UPC 085239266090), while the cucumber-scented wipes include 72-count (UPC 085239265970), 216-count (UPC 085239265994), and 800-count (UPC 085239265987). Target instructed consumers to stop using the recalled wipes and return them to any Target store for a full refund, and provided a Guest Relations number for questions. FDA recall announcement.

In its health-risk language, the FDA said use of products contaminated with the identified Burkholderia organisms may result in serious and life-threatening infections - particularly because the wipes are predominantly used on newborns, infants, and young children. The agency warned that, in healthy individuals, minor skin lesions may lead to more local infections, while in immunocompromised individuals the infection is more likely to spread into the bloodstream, potentially leading to sepsis or pneumonia. FDA recall announcement.

Target also posted the recall on its own consumer-facing “Product recalls” page, listing the Up & Up Fragrance Free and Fresh Cucumber Scented Baby Wipes under its most recent recalls. The listing includes the recall date of 6/4/2026, aligning with the FDA-documented announcement timeline. Target product recalls page.

From a business standpoint, the recall highlights the operational and quality-control burden that can come with selling private-label personal-care items: Target said the wipes were produced by a supplier and that the company and the manufacturer, Sapro Temizlik Urunleri, have received consumer complaints and adverse event reports alleging discoloration, irritation, and infections that may be associated with the wipes. The FDA notice also states the reports “remain under investigation,” and Target said it continues to coordinate with the manufacturer and investigate the matter. FDA recall announcement.

What investors and customers will likely watch next is whether Target provides additional detail on the investigation - such as whether the issue is confined strictly to the listed UPCs and date codes, or whether broader lot/date ranges come into scope. The FDA notice did not quantify recall-related costs (such as refund and logistics expenses) or provide a projected financial impact, so future updates may matter more for evaluating operational exposure than the initial headline. FDA recall announcement.

Why It Matters

  • The recall adds near-term customer-service and reverse-logistics pressure around a high-velocity store-brand category.
  • Because the affected products are identified by specific UPCs and date codes, the ultimate scope of remediation may be constrained - but customers may still need guidance to confirm whether their packages are included.
  • The episode can increase scrutiny of supplier manufacturing controls for Target’s private-label personal-care items.
  • While headlines can move retail sentiment, the absence of disclosed dollar estimates in the FDA posting means later company updates could be the key driver of market reaction.

Sources

Key Facts

  • Target announced a voluntary nationwide recall on June 4, 2026 of select Up & Up Fragrance Free and Fresh Cucumber Scented baby wipes.
  • The FDA said testing identified contamination with Burkholderia cepacia complex and Burkholderia gladioli in product samples.
  • The recall is limited by UPC and manufacturing/expiration code ranges, rather than covering every unit of the product lines.
  • Target told consumers to stop using the affected wipes and return them to any Target store for a full refund.
  • The FDA warned the bacteria may cause serious or life-threatening infections, especially for newborns, infants, young children, and immunocompromised individuals.
  • Target stated it is coordinating with the manufacturer, Sapro Temizlik Urunleri, and that adverse event reports are under investigation.

Retail & Consumer Related

Aug 31, 2:06 PM EDT
The Apex Times

Walmart climbs as oil at $90 bolsters the “defensive” appeal of retailers

Investors are treating cheaper-to-own retail as a buffer again, after a sharp move in crude oil toward $90. The shift could help Walmart capture shoppers “trading down,” but higher fuel and inventory costs also pose a risk to the cash profits that support its valuation.

Walmart climbs as oil at $90 bolsters the “defensive” appeal of retailers
The Apex Times
Target recalls Up & Up baby wipes after FDA testing finds potentially harmful bacteria | The Apex Times